Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF): clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)

• Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
  NCT07031063 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)?

1 recruiting trial across 4 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.